Free Trial
NASDAQ:XOMA

XOMA (XOMA) Stock Price, News & Analysis

XOMA logo
$19.26 -0.67 (-3.36%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About XOMA Stock (NASDAQ:XOMA)

Key Stats

Today's Range
$19.08
$19.70
50-Day Range
$19.30
$27.26
52-Week Range
$18.98
$35.00
Volume
16,581 shs
Average Volume
27,160 shs
Market Capitalization
$231.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$72.00
Consensus Rating
Buy

Company Overview

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Remove Ads

XOMA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

XOMA MarketRank™: 

XOMA scored higher than 92% of companies evaluated by MarketBeat, and ranked 76th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    XOMA has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    XOMA has only been the subject of 1 research reports in the past 90 days.

  • Read more about XOMA's stock forecast and price target.
  • Earnings Growth

    Earnings for XOMA are expected to grow in the coming year, from ($1.41) to ($0.55) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of XOMA is -5.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of XOMA is -5.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    XOMA has a P/B Ratio of 2.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about XOMA's valuation and earnings.
  • Percentage of Shares Shorted

    1.47% of the float of XOMA has been sold short.
  • Short Interest Ratio / Days to Cover

    XOMA has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in XOMA has recently decreased by 7.83%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    XOMA does not currently pay a dividend.

  • Dividend Growth

    XOMA does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.47% of the float of XOMA has been sold short.
  • Short Interest Ratio / Days to Cover

    XOMA has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in XOMA has recently decreased by 7.83%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    XOMA has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for XOMA this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for XOMA on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added XOMA to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, XOMA insiders have sold 12,140.21% more of their company's stock than they have bought. Specifically, they have bought $106,774.00 in company stock and sold $13,069,366.00 in company stock.

  • Percentage Held by Insiders

    Only 7.20% of the stock of XOMA is held by insiders.

  • Percentage Held by Institutions

    95.92% of the stock of XOMA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about XOMA's insider trading history.
Receive XOMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.

XOMA Stock News Headlines

XOMA (NASDAQ:XOMA) Given "Buy" Rating at HC Wainwright
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
StockNews.com Upgrades XOMA (NASDAQ:XOMA) to "Hold"
Q1 Earnings Estimate for XOMA Issued By HC Wainwright
Leerink Partnrs Has Positive Outlook of XOMA FY2025 Earnings
See More Headlines

XOMA Stock Analysis - Frequently Asked Questions

XOMA's stock was trading at $26.28 at the beginning of 2025. Since then, XOMA shares have decreased by 26.6% and is now trading at $19.30.
View the best growth stocks for 2025 here
.

XOMA Co. (NASDAQ:XOMA) posted its quarterly earnings results on Monday, March, 17th. The biotechnology company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of ($0.29) by $0.17. The biotechnology company earned $8.70 million during the quarter, compared to the consensus estimate of $8.75 million. XOMA had a negative net margin of 151.34% and a negative trailing twelve-month return on equity of 24.95%.

Shares of XOMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that XOMA investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
3/17/2025
Today
4/01/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:XOMA
Employees
10
Year Founded
1981

Price Target and Rating

Average Stock Price Target
$72.00
High Stock Price Target
$104.00
Low Stock Price Target
$40.00
Potential Upside/Downside
+267.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-40,830,000.00
Net Margins
-151.34%
Pretax Margin
-138.67%

Debt

Sales & Book Value

Annual Sales
$10.22 million
Price / Cash Flow
N/A
Book Value
$7.72 per share
Price / Book
2.54

Miscellaneous

Free Float
10,935,000
Market Cap
$234.61 million
Optionable
Optionable
Beta
1.00

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:XOMA) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners